RMRC joins WHO network to reduce ‘health inequities'
2
3
Bhubaneswar: The Regional Medical Research Centre (ICMR-RMRC) in the city has been selected to join the WHO's 'Health Inequality Monitoring Network', a global initiative dedicated to advancing health equity through better data and evidence.
Through the network, RMRC will contribute to developing tools, strengthening data systems and guiding policy interventions to reduce health inequities, official sources said.
ICMR director Sanghamitra Pati said Odisha and the rest of the eastern region face significant health challenges, particularly among tribal, rura, and underserved populations. "Being a part of the network will allow RMRC to generate disaggregated data to better understand who is being left behind, support evidence-informed policies to reduce health gaps, and enhance regional health monitoring systems and capacity-building," she added.
"This recognition places ICMR-RMRC Bhubaneswar among key institutions worldwide working to identify and address health disparities. The WHO's recently published report, 'Health Inequality Monitoring: Harnessing Data to Advance Health Equity', emphasises the critical role of monitoring in shaping inclusive health policies," read a press statement from RMRC.
"By collaborating with WHO and other global partners, RMRC will play a critical role in shaping strategies that promote universal health coverage and equity-oriented health reforms," said Pati.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Use an AI Writing Tool That Actually Understands Your Voice
Grammarly
Install Now
Undo
As a participant in the network, she said the RMRC will support WHO in identifying training needs and organising capacity-building workshops for member states. "Our multidisciplinary team of experts will familiarise themselves with WHO's methods and tools on health inequality monitoring and help teams adhere to the shared guidelines," she added.
Pati said RMRC will contribute technical inputs to enhance training programmes, support integration of data disaggregation into health systems and promote best practices. "RMRC will also share knowledge and help develop context-specific training resources to strengthen monitoring capacity across member states," she added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
a minute ago
- Economic Times
IIT Madras graduate was diagnosed with Stage 3 lung cancer at 26. She survived brutal chemo, rebuilt her life and career and made it to Oxford
Synopsis Rasika Bombatkar, diagnosed with Stage 3 lung cancer at 26, faced a grueling battle involving chemotherapy and surgery. Supported by loved ones, she persevered through immense physical and emotional challenges. Defying the odds, Rasika not only survived but also pursued her dreams, earning a degree from Oxford and now working at the World Health Organization. Rasika Bombatkar battled lung cancer stage 3 when she was just 26. (Instagram- @rasikabombatkar) Related At just 26, Rasika Bombatkar—an IIT-Madras graduate—was on a promising career path, working as a research assistant in Tamil Nadu. A routine full-body check-up turned her world upside down. She was diagnosed with Stage 3 lung cancer. The news was devastating, more so because Rasika had never smoked a day in her life. What followed was a harrowing journey of physical pain, emotional breakdowns, and an unshakable will to fight back. The diagnosis left her numb. She couldn't even bring herself to tell her parents and initially shared the news only with her brother, who then informed the family. In the early days, she was overwhelmed—shuffled between tests with no time to breathe. She almost gave up on treatment altogether, too emotionally drained to make any more decisions. That's when a friend stepped in, volunteering to take over the logistics so Rasika could focus on simply surviving. With his support, she began chemotherapy. The treatment was brutal. She lost 10 kilos, her skin broke out in painful rashes, and she covered up every mirror in her house just to avoid seeing herself. Some nights, she admitted, she questioned whether she could even go on. But in the quietest corners of her being—and through the relentless support of her loved ones—she kept finding reasons to push forward. Then came the breakthrough. The tumour had shrunk. Surgery became possible. On December 15th, doctors opened her chest and removed the tumour from her lung. That moment, she said, felt like winning a battle she didn't ask for—but one she refused to lose. It's been two and a half years since that life-changing surgery. While the scars still remain, Rasika has gone on to do the unimaginable. She applied to Oxford—and got in. She's now a graduate of one of the world's most prestigious universities and currently works at the World Health Organisation (WHO) According to her LinkedIn profile, Rasika Bombatkar is currently working as a Technical Advisor at the WHO. She holds a bachelor's degree in Physiotherapy, a master's in Neurophysiotherapy, and an in International Public Health/International Health.
Time of India
25 minutes ago
- Time of India
David Roach dies at 59, after a 'very aggressive' skin cancer battle: All about squamous cell carcinoma
Image credits: X David Roach, a popular 80s rock artist, passed away on August 2, 2025, according to a post shared by the hard rock band Junkyard, reported The Sun. His death comes just two weeks after he got hitched to his wife, Jennifer. The artist, who co-founded the rock band in 1987, was known to be battling a form of aggressive squamous cell carcinoma that affected his head, neck and throat, according to a GoFundMe fundraiser. 'It is with great sadness that we announce the passing of David Roach,' the band said in the social media post. "After a courageous battle with cancer, David passed away peacefully last night at home, in the loving arms of his wife." 'He was a gifted artist, performer, songwriter, and singer – but above all, a devoted father, husband, and brother. Our thoughts are with the entire Roach family and everyone who loved him.' What is squamous cell carcinoma ? Image credits: Getty Images Squamous cell carcinoma is the second most common form of skin cancer in the US, with an estimated 1.8 million cases diagnosed in the US each year. It is a type of skin cancer that starts in the skin cells known as squamous cells. While the cancer is not life-threatening, it can spread to other parts of the body if not treated. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Is Why Smart People Put Baking Soda in Their Shampoo Read More Undo The most common cause of skin cancer is ultraviolet (UV) radiation, which comes either from sunlight or lamps. The symptoms of the disease include a firm bump on the skin, a sore with a scaly crust, a rough patch on the lip or inside the mouth, and more. It mostly happens in the skin that is exposed to the sun, such as the scalp and hands, ears or lips, but can occur anywhere else in the body as well. It is important to visit a doctor if a sore or scab doesn't heal in about two months as it could be the development of the skin cancer. Roach had recently tied the knot with his fiancée, Jennifer Roach, and the same was announced on the band's Instagram page with the caption, "Congratulations to the happy couple — Mr. and Mrs. David Patrick Roach ♠️❤️"
India Today
30 minutes ago
- India Today
What is hepatitis D, the deadly viral disease now given a cancer tag by WHO?
Hepatitis D is now tagged as a cancer-causing infection by the World Health Organisation. The health agency's cancer arm, the International Agency for Research on Cancer, called hepatitis D a carcinogen as the little-known virus can silently raise the risk of liver cancer, just like hepatitis B and is a viral infection that inflames the liver. Of the five main types – A, B, C, D and E – the B, C and D strains are the most dangerous because they can stick around for years, damaging the liver estimates that over 300 million people live with chronic hepatitis B, C, or D infections, and 1.3 million die each year from related diseases. Most don't even know they're infected until the damage is already done. Hepatitis D is different from the others. It only infects people who already have hepatitis B, but together, the two viruses are far more harmful. According to WHO, having both increases the risk of liver cancer two to six times compared to hepatitis B virus spreads through infected blood, unprotected sex, unsafe injections, or occasionally from mother to child during if they appear, are usually vague and includes fatigue, nausea, abdominal discomfort, dark urine or yellowing of the skin. Many people ignore these signs or confuse them with other isn't a separate vaccine for hepatitis D. The only way to stop it is by getting the hepatitis B vaccine, which protects against both viruses. WHO says 147 countries now offer newborn vaccinations, but testing and treatment for existing cases still lag far it comes to the treatment of hepatitis D, medications are still evolving. However, the full benefit of reducing liver cirrhosis and cancer deaths can only be realised through urgent action to scale up and integrate hepatitis services – including vaccination, testing, harm reduction, and treatment – into national health experts say better awareness, early screening and wider access to treatment could save millions of lives by 2030. For now, the key advice is simple: get vaccinated, get tested, and don't ignore liver health.- Ends
